Recalling firm
Eugia US LLC
Product type
Drug
Status
Ongoing
Report date
2025-04-23
Distribution
Nationwide USA
Firm state
NJ
Product quantity
36,816 vials
Initiated by
Voluntary: Firm initiated
SPEQ quality domain
Risk Management & CAPAReason for recall
cGMP: complaints of crystals not redissolving into solution after warming and shaking the vials.
Product description
Testosterone Cypionate Injection, USP, CIII, 200mg per mL, Rx only, 1mL Single-Dose Vial, Distributed by Eugia US LLC, E. Windsor, NJ, Manufactured by: Eugia Specialties Limited, Telangana State, India, NDC 55150-277-01
Code / lot info
Lot #: 1TC24075A, Exp 11/30/2026.
Other recalls SPEQ maps to Risk Management & CAPA
See all Risk Management & CAPA recalls →Data: U.S. FDA openFDA enforcement API. Recall details are as reported by the FDA. The quality-domain mapping and severity are a SPEQ editorial interpretation of the recall reason, not an official FDA classification.